header

Obesity-news.com
THE LATEST IN OBESITY RESEARCH AND WEIGHTLOSS DRUG DEVELOPMENT

    Join our list More information

    

Archives

You may subscribe to Obesity-news on-line using our secure server. Our subscription information form is available 24 hours a day! We also take fax orders at 703/960-7462. Obesity-news accepts most major credit cards: American Express, Visa and Mastercard.

JUNE 2009

ISIS PIPELINE UPDATE

XOMA PIPELINE UPDATE

MAY 2009

AMYLIN PIPELINE UPDATE

CONTRAVE UPDATE

TESOFENSINE UPDATE

CLINICAL COMPOUNDS UPDATE

APRIL 2009

METABASIS PIPELINE UPDATE

MARCH 2009

LORCASERIN PHASE III RESULTS

LIRAGLUTIDE NDA DATA

FEBRUARY 2009

QNEXA PHASE III RESULTS

NOVEMBER 2008

OBESITY SOCIETY MEETING HIGHLIGHTS

SEPTEMBER 2008

EASD MEETING HIGHLIGHTS

JUNE 2008

ADA MEETING HIGHLIGHTS

MARCH/APRIL 2008

WINTER DRUG UPDATE: PART II

JANUARY/FEBRUARY 2008

WINTER DRUG UPDATE

DECEMBER 2007

FALL DRUG UPDATE

SEPTEMBER 2007

EASD 2007 MEETING

JULY 2007

ENDOCRINE SOCIETY 2007 MEETING

JUNE 2007

ADA SCIENTIFIC SESSION

JANUARY-FEBRUARY 2007

WINTER CONFERENCE UPDATE

SEPTEMBER-OCTOBER 2006

CLINICAL DRUG CALENDAR WEIGHT LOSS DRUGS: PART II

FALL CONFERENCES

AUGUST 2006

CLINICAL DRUG CALENDAR WEIGHT LOSS DRUGS: PART I

JULY 2006

SPRING CONFERENCES

JUNE 2006

SPRING CONFERENCES

MARCH - MAY 2006

EXPERIMENTAL BIOLOGY 2006

FEBRUARY 2006

WINTER CONFERENCE UPDATE PART II

  • Full text. (TOC unrestricted access, articles subscribers)
JANUARY 2006

WINTER CONFERENCE UPDATE

  • Full text. (TOC unrestricted access, articles subscribers)
OCTOBER-DECEMBER 2005

WHAT'S IN THE CLINIC: UPDATE ON PHASE I-III COMPOUNDS

DIETARY SUPPLEMENTS

AUGUST/SEPTEMBER 2005

DIETARY SUPPLEMENTS

JULY 2005

87th ANNUAL MEETING OF THE ENDOCRINE SOCIETY

EXPERIMENTAL BIOLOGY 2005

ADP356 PHASE II RESULTS

JUNE 2005

ADA 65TH SCIENTIFIC SESSIONS

MAY 2005

BYETTA (EXENATIDE) APPROVAL CONFERENCE CALL

MARCH 2005

BIO "ADVANCES IN OBESITY DRUGS"

FEBRUARY 2005

WEIGHT LOSS DRUGS UPDATE

DECEMBER 2004/JANUARY 2005

GENETICS UPDATE

NOVEMBER 2004

FALL CONFERENCES

OCTOBER 2004

NEW DRUG AND GENETICS NEWS

SEPTEMBER/OCTOBER 2004

WEIGHT LOSS DRUG REVIEWS

JULY/AUGUST 2004

OMR's NEW DRUG DATABASE

SUMMER CONFERENCES

MAY/JUNE 2004

WEIGHT LOSS DRUG DEVELOPMENT UPDATE

SUMMER CONFERENCES

OCTOBER-DECEMBER 2003

WEIGHT LOSS DRUGS IN DEVELOPMENT REPORT.

APPENDIX

SEPTEMBER 2003

GENETICS UPDATE

AUGUST 2003

MORE DIABETES NEWS

JULY 2003

SUMMER CONFERENCES

JUNE 2003

FOCUS ON INSULIN RESISTANCE AND OBESITY

APRIL/MAY 2003

MORE NEW DRUG NEWS

APRIL 2003

AXOKINE PHASE 3 RESULTS: ANALYSIS AND TRANSCRIPT

MARCH 2003

NEW DRUG NEWS

FEBRUARY 2003

WEIGHT LOSS DRUGS AND GENETICS UPDATE

JANUARY 2003

SPECIAL REPORT: AXOKINE GRANTED FAST TRACK STATUS

OCTOBER-DECEMBER 2002

WEIGHT LOSS DRUGS IN DEVELOPMENT REPORT.

APPENDICES

SEPTEMBER 2002

MEETING ABSTRACTS

JULY/AUGUST 2002

PRESCRIPTION AND OTC DRUGS UPDATE

MAY/JUNE 2002

THE GLYCEMIC INDEX

REVIEW ARTICLE

MAY 2002

EXPERIMENTAL BIOLOGY 2002 ABSTRACTS

APRIL 2002

WILL MERIDIA BE BANNED?

MARCH 2002

UPDATE ON AXOKINE.

FEBRUARY 2002

DRUGS IN DEVELOPMENT UPDATE.

JANUARY 2002

INSULIN RESISTANCE, GENETICS AND OBESITY.

OCTOBER-DECEMBER 2001

WEIGHT LOSS DRUGS IN DEVELOPMENT REPORT.

SEPTEMBER 2001

XENICAL AND YOUR BONES.

REVIEW ARTICLE

SEPTEMBER 2001
SUPPLEMENTS

CONFERENCE COVERAGE.

AUGUST 2001

SPECIAL REPORT ON AXOKINE: PHASE 3 TRIAL DETAILS.

JULY/AUGUST 2001
SUPPLEMENTS

SUMMER CONFERENCES COVERAGE

REVIEW ARTICLE

JULY 2001

GETTING RID OF THE XENICAL BLUES

JUNE 2001

EFFECTIVE WEIGHT LOSS DRUGS: NOT JUST FOR RATS ANYMORE!

JUNE 2001 SUPPLEMENTS

SPECIAL REPORT

AMERICAN COLLEGE OF SPORTS MEDICINE HIGHLIGHTS.

APRIL/MAY 2001

LOSE WEIGHT AND KEEP IT OFF?

MARCH 2001

CANNABINOIDS AND BODY WEIGHT

REVIEW ARTICLE

FEBRUARY 2001

METABOLISM AND OBESITY

JANUARY 2001

SOLVING THE PHENTERMINE SHORTAGE

DECEMBER 2000/
JANUARY 2001

GENETICS AND DRUG DEVELOPMENT UPDATE

DECEMBER 2000
SUPPLEMENTS

AXOKINE PHASE 2 TRIAL RESULTS

FALL CONFERENCE ABSTRACTS

NOVEMBER 2000

SPECIAL COVERAGE OF THE NAASO ANNUAL MEETING

HIGHLIGHTS OF THE ASBP ANNUAL MEETING

OCTOBER 2000

ANNUAL DRUGS IN DEVELOPMENT ISSUE

SEPTEMBER 2000
AUGUST 2000

DOES A VIRUS CAUSE OBESITY?

AUGUST 2000
SUPPLEMENT

THE PHENTERMINE SHORTAGE

JULY 2000

KNOW WHY YOU GET THE MUNCHIES?

SUPPLEMENT: ENDO 2000.

JUNE 2000
MAY 2000

SPECIAL COVERAGE OF EXPERIMENTAL BIOLOGY 2000

APRIL 2000

IS THERE A DIET DRUG CONSPIRACY?

FEBRUARY/MARCH 2000

NEWS ONLY SECTION PARTS 1 AND 2

FEBRUARY 2000

METFORMIN AND WEIGHT LOSS

DEC 1999/JAN 2000

DOUBLE ISSUE ON LEPTIN

EXPERIMENTAL BIOLOGY ABSTRACTS

NOVEMBER 1999

SPECIAL COVERAGE OF THE NAASO ANNUAL MEETING

OCTOBER 1999

ANNUAL DRUGS IN DEVELOPMENT ISSUE

SEPT/OCT 1999

CAN FENFLURAMINE BE REPLACED?

SEPTEMBER 1999
AUGUST 1999

OTC SUPPLEMENTS AND MEDICATIONS.

JULY 1999
JUNE 1999
APRIL/JUNE 1999
REVIEW ARTICLE
MAY 1999
APRIL 1999
MARCH 1999
JAN/FEB 1999

SEROTONIN, EATING DISORDERS AND OBESITY.

DECEMBER 1998
NOVEMBER 1998
OCTOBER 1998

ANNUAL DRUGS IN DEVELOPMENT ISSUE

SEPTEMBER 1998
AUGUST 1998
JULY 1998
JUNE 1998
MAY 1998
APRIL 1998
APRIL 1998
REVIEW ARTICLES
MARCH 1998
FEBRUARY 1998

MERIDIA GOES TO MARKET

JANUARY 1998
DECEMBER 1997
NOVEMBER 1997
OCTOBER 1997
SEPTEMBER 1997
AUGUST 1997
JULY 1997
JUNE 1997

header

Obesity-news is a publication of Hirsch Communications. An on-line subscription is $104.00 per month, payable in advance by American Express, VISA or Mastercard. Subscribing is simple using our secure on-line subscription form. A yearly subscription is also available for $1040 per year through EBSCO or Swets Blackwell subscription services. Please contact them for more information. Obesity-news also accepts fax orders at 703/960-7462. Copyright 1997-2013, all rights reserved.

IMPORTANT: All information in this publication is believed to be accurate and true. Publisher is not liable for omissions or inaccuracies. Information in this newsletter is for educational purposes only and should not be construed as medical advice, or be used in lieu of consultation with a health care provider.